ELAVL1 and cancer: Given that HuR may regulate EGFR pathway signaling through mRNA stabilization and that the A peptide can target EGFR on cells, we verified protein expression by Western blotting, as shown in Fig. 7A. Furthermore, several studies have indicated that docetaxel treatment may induce a decrease in p-EGFR expression in different cancer types, potentially bolstering its anti-tumor properties (Hashemi et al. 2023).